Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
09/29/2011 | WO2010127152A3 Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors |
09/29/2011 | US20110237792 Quinoline derivatives and their use as 5-ht6 ligands |
09/29/2011 | US20110237776 Aromatic compounds with sulfur containing ligands |
09/29/2011 | US20110237599 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
09/29/2011 | US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
09/29/2011 | US20110237580 Substituted bicyclic imidazole derivatives as gamma secretase modulators |
09/29/2011 | US20110237576 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having bace1-inhibiting activity |
09/29/2011 | US20110237575 Inhibitors of fatty acid binding protein (fabp) |
09/29/2011 | US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
09/29/2011 | US20110237570 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors |
09/29/2011 | US20110237567 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
09/29/2011 | US20110237565 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
09/29/2011 | US20110237564 Imidazopyrimidine derivatives |
09/29/2011 | US20110237517 Iap inhibitors |
09/29/2011 | DE102010013068A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices |
09/29/2011 | CA2794153A1 Chemical compounds |
09/29/2011 | CA2794003A1 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
09/29/2011 | CA2792339A1 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors |
09/29/2011 | CA2786900A1 Pyrrolopyrazine kinase inhibitors |
09/29/2011 | CA2786402A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors |
09/29/2011 | CA2786213A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors |
09/28/2011 | EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
09/28/2011 | EP2367829A1 Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
09/28/2011 | EP2367828A1 Process for the preparation of tetrazine derivatives |
09/28/2011 | EP2367827A1 3-(3-pyrimidine-2-yl-benzyl)-ý1,2,4¨triazolo ý4,3-b¨pyridazine derivatives |
09/28/2011 | EP2367820A2 Novel antimicrobials |
09/28/2011 | EP2367598A2 Inhibitors of diacylglycerol acyltransferase |
09/28/2011 | EP2367431A1 Organic compounds |
09/28/2011 | EP2367430A1 Organic compounds |
09/28/2011 | EP2367429A1 Organic compounds |
09/28/2011 | EP2367428A1 Organic compounds |
09/28/2011 | EP2041137B1 Pyrrolopyrimidines for pharmaceutical compositions |
09/28/2011 | EP2041131B1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
09/28/2011 | EP1620525B1 Organic electroluminescent device and platinum compound |
09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
09/28/2011 | CN1980661B Cationic bacteriochlorophyll derivatives and uses thereof |
09/28/2011 | CN102203098A Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors |
09/28/2011 | CN102203097A Novel tricyclic chiral compounds and their use in asymmetric catalysis |
09/28/2011 | CN102203096A Compounds that expand hematopoietic stem cells |
09/28/2011 | CN102203067A Hedgehog pathway modulators |
09/28/2011 | CN102203063A Carbazole compounds and therapeutic uses of the compounds |
09/28/2011 | CN102201540A Organic electroluminescence component |
09/28/2011 | CN102199153A Method for preparing sodium copper chlorophyllin by using silkworm excrement as raw material |
09/28/2011 | CN102199152A Heterocycle imidazoles phosphatide kinases inhibitor |
09/28/2011 | CN102199116A Fluoro imido sugar compounds, and preparation method and application thereof |
09/28/2011 | CN102199102A Sitagliptin intermediate and preparation method and application thereof |
09/28/2011 | CN101759699B Pyrro-perhydroazepinone compound and application thereof in preparing medicaments for treating tumors |
09/28/2011 | CN101544644B Preparation method of mianserin hydrochloride |
09/27/2011 | US8026358 Process for preparing porphyrin derivatives, such as protoporphyrin (IX) and synthesis intermediates |
09/27/2011 | US8026264 Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1 |
09/27/2011 | US8026234 Polo-like kinase inhibitors |
09/27/2011 | US8025988 Reactive organometallic dendrimers |
09/27/2011 | CA2611750C Red-shifted water-dispersible naphthalocyanine dyes |
09/27/2011 | CA2503646C Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
09/27/2011 | CA2487748C Composition for dyeing keratinous fibres containing at least one derivative of diamino-n,n-dihydropyrazolone |
09/27/2011 | CA2415847C Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
09/22/2011 | WO2011116371A2 Polyplex gene delivery vectors |
09/22/2011 | WO2011115813A1 Lactam acetamides as calcium channel blockers |
09/22/2011 | WO2011114275A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
09/22/2011 | WO2011114160A1 Anagrelide derivatives (imidazo [2, 1-b] quinazolin - 2 - ones ) as pde iii inhibitors useful as antithrombotic agents |
09/22/2011 | WO2011114148A1 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists |
09/22/2011 | WO2011114109A1 Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3 -methyl-4,10-dihydro-3h-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide |
09/22/2011 | WO2011113862A1 Imidazopyrazines |
09/22/2011 | WO2011113606A1 Anti-infective compounds |
09/22/2011 | WO2011113399A1 Method of preparing sitagliptin |
09/22/2011 | WO2011080510A8 Tricyclic compounds for use as kinase inhibitors |
09/22/2011 | WO2011071360A3 Synthesis of 8-aminoboron-dipyrromethenes having blue fluorescence |
09/22/2011 | WO2009111653A3 Antiviral therapeutic agents |
09/22/2011 | US20110230658 Process for the preparation of tetrazine derivatives |
09/22/2011 | US20110230508 Novel Forms of a Fused Pyrrolocarbazole Compound |
09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
09/22/2011 | US20110230476 Pi3 kinase inhibitors and uses thereof |
09/22/2011 | US20110230472 Ring-fused azole derivative having pi3k-inhibiting activity |
09/22/2011 | US20110230468 Fused heterocyclic compounds and uses thereof |
09/22/2011 | US20110230465 Viral polymerase inhibitors |
09/22/2011 | US20110230464 Purine derivatives useful as p13 kinase inhibitors |
09/22/2011 | US20110230462 Pyrrolopyrazine Kinase Inhibitors |
09/22/2011 | US20110230459 Lactam acetamides as calcium channel blockers |
09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
09/22/2011 | CA2793663A1 Polyplex gene delivery vectors |
09/22/2011 | CA2793641A1 Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3 -methyl-4,10-dihydro-3h-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide |
09/22/2011 | CA2793279A1 Imidazopyrazines |
09/22/2011 | CA2793181A1 Nanotubes and compositions thereof |
09/22/2011 | CA2793125A1 New enzyme inhibitor compounds |
09/22/2011 | CA2793086A1 Anti-infective compounds |
09/22/2011 | CA2791737A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
09/21/2011 | EP2365970A1 Pyridazinones and their use as btk inhibitors |
09/21/2011 | EP2365748A1 Imidazoisoindole neuropeptide s receptor antagonists |
09/21/2011 | EP1966202B1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
09/21/2011 | EP1675860B1 Imidazo[1,5-a]pyrazines as tyrosine kinase inhibitors |
09/21/2011 | EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase |
09/21/2011 | CN102197038A Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
09/21/2011 | CN102190669A Dihydro pteridinone derivatives, preparation method thereof and application thereof in medicines |
09/21/2011 | CN102190660A N-F Troger type quaternary ammonium salt and preparation method thereof |
09/21/2011 | CN102190659A Phenylpyrazine compounds, and preparation method and medicinal application thereof |
09/21/2011 | CN102190621A N-heterocyclyl-phenylsubstituierte cyclische ketoenole |
09/20/2011 | US8022295 Photoelectric conversion devices |
09/20/2011 | US8022207 Compound having affinity to amyloid |
09/20/2011 | US8022083 Antiviral phosphonate analogs |
09/20/2011 | US8022075 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |